Chapter 23 Important Decisions
"An invitation from Bayer?"
After hearing John's words, Mr. Brister was shocked.
"Yes, Bayer's invitation."
Shrugging, John smiled slightly and said, "This weekend's dance party is said to have invited many prestigious gentlemen in Berlin...father-in-law, have you not received it?"
“Of course, I received it, too.
Frowning, Brister's expression quickly became serious.
In the domestic chemical industry in Germany, Bayer is comparable to BASF. This company that started with dyes has developed very rapidly and has become a real dye giant in just a few decades. As the German dye industry gradually occupied the dominance of the world, Bayer's scale has become increasingly large. Following John's Heinz Pharmaceutical Company, investing two million marks to build the second large-scale laboratory in Germany, which is 500,000 marks more than in history!
Unfortunately, the Medicine of the Century no longer belongs to Bayer.
Aspirin, which originally brought Bayer unimaginable profits in history, has now become the flagship product of Heinz Pharmaceuticals and has been deeply rooted in the hearts of the people around the world. With its advanced production technology, the "low" cost and the name aspirin that doctors say is easy to say, basically accounts for more than 80% of the market. Even if the British, French and Germans have recently developed the production process of yixian salicylic acid, it is not possible to shake the dominance of aspirin...
“Bayer has always been interested in aspirin and sulfa.”
After pondering slightly, Brister took a deep breath and said, "In fact, it's not just Bayer. In the past two years, BASF has sent people to visit me many times, seeking aspirin and sulfa production authorization, but I have blocked them back, so they used some shameful means to poach many researchers from our company."
"Haha, I've heard of these things."
With a smile, John did not show any special emotions. Brister had written to tell him about these things, so naturally there was nothing to be surprised about. Moreover, John from the future is easy for people to change jobs and is also easy to accept.
"I'm afraid the same purpose is to invite you this time!"
After thinking about it, Brister warned: "John, what Bayer values most is aspirin, especially in the past two years, not only has we repeatedly asked us to authorize production, but we have never stopped researching and developing production processes. We must be careful!"
"Haha, don't worry, father-in-law."
After hearing this, John felt a strange feeling in his heart and couldn't help laughing. In real history, Bayer was the "victim" of the Aspirin War, but in this world, they became attempts to disrupt the situation. This role reversal is really interesting.
However, after laughing, John shook his head and said, "Father-in-law, I won't go to this dance... Well, I've been in a closed door for some time recently, so it's not targeting them. You can meet them and talk to them! If they still ask about authorized production, then you can tell them directly that I can seriously consider authorizing them to produce yixian salicylic acid!"
"What?"
Hearing this, Brister was shocked and stood up and asked anxiously: "John, you, are you planning to authorize Bayer to produce aspirin?"
"It's not aspirin, it's yixian salicylic acid!"
With a faint smile, John said calmly.
In John's view, if Bayer can pay the price to satisfy him, what's wrong with one more competitor? It's just that the production process of yixian salicylic acid. As long as the trademark of aspirin is still in his own hands, other companies are destined to be unable to turn to heaven! In fact, John has considered it many times in the past two years. If Bayer paid enough, he was even willing to transfer part of the shares of Heinz Pharmaceuticals!
There is no doubt that Heinz Pharmaceuticals is a golden chicken laying eggs.
However, as Heinz Pharmaceuticals became increasingly powerful, John gradually felt pressure from all sides - such as the covetousness of consortiums such as Morgan, the exploration of many old nobles and merchants in Germany, and even the pressure from the German government and the military! You should know that due to the amazing effects of several drugs, the German side purchases millions of marks every year, which is a considerable expense. So even if no one proposed it openly, John and Old Hunteral had already felt a lot of things.
This is like General Motors in Karlsruhe.
The more mature the car technology and the more it appears on the streets, the more John can feel the restlessness of General Motors. Benz repeatedly proposed to expand the scale unrealistically, just by introducing investors? Although the newly emerging competitors' cars in the past two years are simple and far from comparable to Aurora, some of the technologies obviously use General Motors' patents, which makes John and his grandfather a little uneasy.
So before coming to Europe, the grandfather and grandson finally made up their minds.
Of course, European industries do not want to give up, nor can they give up, but the Hunteral family is small, and it is impossible for anyone to stay in Europe in the future. The larger the industry, the more likely it is to cause uneasiness to the government. Take Heinz Pharmaceutical for example. The monopoly of aspirin and sulfamide is too strong, and its role in this era is irreplaceable. Of course, the German government is not assured that they have been held by American companies.
Today's Heinz Pharmaceuticals is too large!
The sales of tens of millions of marks each year and the net profit exceeds 10 million marks. This number is too huge for the German government, so large that they cannot accept it. So like the cooperative companies in the UK and France, the Hunteral family gradually reduces the proportion of industrial shares and appropriately introduces local funds. After all, the Hunteral family's future focus is in the United States, and in New York, where is their base camp!
Moreover, in addition to getting a lot of cash, John believes that losing some shares will not have much impact.
As early as a few years ago, Heinz Pharmaceuticals and Hunteral R&D Center were completely separated. Today, Heinz Pharmaceuticals is a pure factory and does not have the ability to develop new drugs. In fact, the chemical and industrial levels of this era are still too low, and it is not easy to develop new drugs. Heinz Research Center invests millions of marks every year, and has only developed several new sulfonamide drugs. Without John's active guidance, their path is still long and difficult.
So facing my father-in-law's shocked expression, John said seriously: "That's it. We can transfer the production process of yixian salicylic acid, but we will never transfer the trademark use rights of aspirin! In addition, father-in-law, if there is a suitable opportunity, you can also talk to the German government. Perhaps Heinz Pharmaceuticals' shares can also be appropriately sold..."
...
Yixian salicylic acid is also a sensitive word?
Chapter completed!